A 2-year dose-response study of lesion sequences during hepatocellular carcinogenesis in the male B6C3F(1) mouse given the drinking water chemical dichloroacetic acid.
Open Access
- 1 January 2003
- journal article
- Published by Environmental Health Perspectives in Environmental Health Perspectives
- Vol. 111 (1) , 53-64
- https://doi.org/10.1289/ehp.5442
Abstract
Dichloroacetic acid (DCA) is carcinogenic to the B6C3F(1) mouse and the F344 rat. Given the carcinogenic potential of DCA in rodent liver and the known concentrations of this compound in drinking water, reliable biologically based models to reduce the uncertainty of risk assessment for human exposure to DCA are needed. Development of such models requires identification and quantification of premalignant hepatic lesions, identification of the doses at which these lesions occur, and determination of the likelihood that these lesions will progress to cancer. In this study we determined the dose response of histopathologic changes occurring in the livers of mice exposed to DCA (0.05-3.5 g/L) for 26-100 weeks. Lesions were classified as foci of cellular alteration smaller than one liver lobule (altered hepatic foci; AHF), foci of cellular alteration larger than one liver lobule (large foci of cellular alteration; LFCA), adenomas (ADs), or carcinomas (CAs). Histopathologic analysis of 598 premalignant lesions revealed that (a)) each lesion class had a predominant phenotype; (b)) AHF, LFCA, and AD demonstrated neoplastic progression with time; and (c)) independent of DCA dose and length of exposure effects, some toxic/adaptive changes in non-involved liver were related to this neoplastic progression. A lesion sequence for carcinogenesis in male B6C3F(1) mouse liver has been proposed that will enable development of a biologically based mathematical model for DCA. Because all classes of premalignant lesions and CAs were found at both lower and higher doses, these data are consistent with the conclusion that nongenotoxic mechanisms, such as negative selection, are relevant to DCA carcinogenesis at lower doses where DCA genotoxicity has not been observed.Keywords
This publication has 43 references indexed in Scilit:
- Effects of dichloroacetate on glycogen metabolism in B6C3F1 mice1Presented in part at the 34th Annual Meeting of the Society of Toxicology, March 1995, Baltimore, MD, USA.1Toxicology, 1998
- Dichloroacetate and Trichloroacetate Promote Clonal Expansion of Anchorage-Independent Hepatocytesin Vivoandin VitroToxicology and Applied Pharmacology, 1998
- Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liverCarcinogenesis: Integrative Cancer Research, 1997
- Differences in Phenotype and Cell Replicative Behavior of Hepatic Tumors Induced by Dichloroacetate (DCA) and Trichloroacetate (TCA)Toxicology and Applied Pharmacology, 1997
- In vivo genotoxicity of dichloroacetic acid: Evaluation with the mouse peripheral blood micronucleus assay and the single cell gel assayEnvironmental and Molecular Mutagenesis, 1996
- Biochemical, pathologic and morphometric alterations induced in male B6C3F1 mouse liver by short-term exposure to dichloroacetic acidToxicology Letters, 1995
- Immunohistochemical analysis of dichloroacetic acid (DCA)-induced hepatocarcinogenesis in male Fischer (F344) ratsCancer Letters, 1995
- Early induction of reparative hyperplasia in the liver of B6C3F1 mice treated with dichloroacetate and trichloroacetateToxicology, 1990
- Preneoplastic lesions as end points in carcinogenicity testing I. Hepatic preneoplasiaCarcinogenesis: Integrative Cancer Research, 1986
- Metabolic Effects of Dichloroacetate in Patients with Diabetes Mellitus and HyperlipoproteinemiaNew England Journal of Medicine, 1978